Drug Manufacturers—General Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12 |  LLY Eli Lilly and Company Common Stock | 1169.93 USD | -1.55% | +1.53% | +3.99% | +36.50% | 1.10 T USD | ||
| 20 |  JNJ Johnson & Johnson Common Stock | 256.49 USD | -0.71% | -1.00% | -5.18% | +33.58% | 618.11 B USD | ||
| 23 |  ABBV AbbVie Inc. Common Stock | 272.42 USD | +0.41% | +5.17% | +8.43% | +17.57% | 481.40 B USD | ||
| 35 |  MRK Merck & Company, Inc. Common Stock | 142.40 USD | -0.25% | -0.95% | -3.66% | +62.21% | 351.33 B USD | ||
| 47 |  NVS Novartis AG | 143.12 USD | -0.10% | +1.18% | +3.13% | +8.58% | 273.09 B USD | ||
| 66 |  AMGN Amgen Inc. - Common Stock | 407.44 USD | -1.37% | -0.66% | +5.05% | +37.57% | 220.28 B USD | ||
| 82 |  GILD Gilead Sciences, Inc. - Common Stock | 147.10 USD | +0.17% | -0.41% | +1.40% | +25.27% | 182.40 B USD | ||
| 99 |  PFE Pfizer, Inc. Common Stock | 27.83 USD | -0.57% | -0.96% | +0.29% | +10.04% | 158.62 B USD | ||
| 125 |  BMY Bristol-Myers Squibb Company Common Stock | 59.56 USD | -0.20% | -2.28% | -8.11% | +33.72% | 121.66 B USD | ||
| 154 |  GSK GSK plc American Depositary Shares | 46.52 USD | -1.06% | -1.13% | -4.02% | +6.09% | 100.38 B USD | ||
| 161 |  SNY Sanofi - American Depositary Shares | 40.23 USD | +0.07% | +1.46% | -6.14% | -17.86% | 98.12 B USD | ||
| 371 |  ONC BeOne Medicines Ltd - American Depositary Shares | 350.13 USD | -3.82% | -0.38% | +2.51% | +10.91% | 39.81 B USD | ||
| 423 |  BIIB Biogen Inc. - Common Stock | 218.43 USD | -1.67% | -1.98% | +4.05% | +45.62% | 32.27 B USD | ||
| 1220 |  CGON CG Oncology, Inc. - Common stock | 63.26 USD | +1.41% | -8.78% | -10.79% | +45.22% | 5.61 B USD | ||
| 1264 |  MANE Veradermics, Incorporated Common Stock | 126.68 USD | +13.94% | +5.28% | +28.57% | +283.88% | 5.29 B USD | ||
| 1286 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 77.28 USD | -2.79% | -9.66% | -14.33% | +140.97% | 5.12 B USD | ||
| 1534 |  OGN Organon & Co. Common Stock | 13.76 USD | -0.15% | +0.29% | +0.73% | +89.53% | 3.61 B USD | ||
| 1780 |  MBX MBX Biosciences, Inc. - Common Stock | 53.25 USD | -2.37% | -10.17% | -14.70% | +234.91% | 2.56 B USD | ||
| 1985 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 131.34 USD | +0.57% | -2.82% | -11.51% | +77.85% | 1.89 B USD | ||
| 2025 |  GENB Generate Biomedicines, Inc. - Common Stock | 13.99 USD | +3.10% | +0.43% | -8.68% | -6.73% | 1.80 B USD |
Nouvelles Drug Manufacturers—General Stocks
SOPHiA GENETICS et Myriad Genetics collaborent pour faire progresser une nouvelle technologie d’indice d’instabilité génomique spécifique au cancer de la prostate
Cantor Fitzgerald relève son objectif de cours sur Pfizer
Northern Discovery acquiert le projet cuivre-or Cibola en Colombie-Britannique
Cantor Fitzgerald relève son objectif de cours sur Merck avec une perspective 2027
Cantor Fitzgerald abaisse l’objectif de cours de Bristol-Myers Squibb à 53$
Cantor Fitzgerald relève son objectif de cours sur Eli Lilly
Cantor Fitzgerald relève son objectif de cours sur Amgen grâce à la solidité du portefeuille
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
 OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
 CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
 QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
 MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
 APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
 SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
 IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |